Stephen P. MacMillan Discloses SEC Filing 144 Report

In a recent SEC filing, Stephen P. MacMillan reported a Form 144. This form is filed with the Securities and Exchange Commission to notify of the intent to sell restricted stock. MacMillan is a well-known figure in the business world, having previously served as the CEO of medical device company Stryker Corporation.

Form 144 filed by MacMillan indicates his intention to sell shares of a company where he holds a significant stake. Investors and market analysts often keep a close watch on such filings as they can provide insights into the actions of key insiders within a company. MacMillan’s filing may signal his plans to divest some of his holdings, which could have implications for the company’s stock price.

For more information on Stephen P. MacMillan and his business activities, you can visit his profile on the SEC’s EDGAR database here.

Read More:
Stephen P. MacMillan (0001239351) Submits Form 144 Filing to SEC


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *